List of Excipients in API carbamazepine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing carbamazepine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | TEGRETOL | carbamazepine | 0078-0508 | CITRIC ACID MONOHYDRATE | |
| Novartis Pharmaceuticals Corporation | TEGRETOL | carbamazepine | 0078-0508 | FD&C YELLOW NO. 6 | |
| Novartis Pharmaceuticals Corporation | TEGRETOL | carbamazepine | 0078-0508 | POTASSIUM SORBATE | |
| Novartis Pharmaceuticals Corporation | TEGRETOL | carbamazepine | 0078-0508 | PROPYLENE GLYCOL | |
| Novartis Pharmaceuticals Corporation | TEGRETOL | carbamazepine | 0078-0508 | SORBITOL | |
| Novartis Pharmaceuticals Corporation | TEGRETOL | carbamazepine | 0078-0508 | SUCROSE | |
| Novartis Pharmaceuticals Corporation | TEGRETOL | carbamazepine | 0078-0508 | WATER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing carbamazepine
Detailed excipient profiles for carbamazepine
Excipient focus: ACACIA
carbamazepine drug variants containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | carbamazepine | 63629-8743 |
| Bryant Ranch Prepack | carbamazepine | 63629-9292 |
| REMEDYREPACK INC | carbamazepine | 70518-3694 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing ACACIA
Excipient focus: ALUMINUM OXIDE
carbamazepine drug variants containing ALUMINUM OXIDE
carbamazepine drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIA
carbamazepine drug variants containing AMMONIA
carbamazepine drug variants not containing AMMONIA
Excipient focus: AMMONIO METHACRYLATE COPOLYMER TYPE A
carbamazepine drug variants containing AMMONIO METHACRYLATE COPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0407 |
| Taro Pharmaceuticals USA Inc | carbamazepine | 51672-4151 |
| Takeda Pharmaceuticals America Inc | carbamazepine | 54092-171 |
| American Health Packaging | carbamazepine | 60687-311 |
| Prasco Laboratories | carbamazepine | 66993-407 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing AMMONIO METHACRYLATE COPOLYMER TYPE A
Excipient focus: ANHYDROUS CITRIC ACID
carbamazepine drug variants containing ANHYDROUS CITRIC ACID
carbamazepine drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BROWN IRON OXIDE
carbamazepine drug variants containing BROWN IRON OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AustarPharma LLC | carbamazepine | 35561-355 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing BROWN IRON OXIDE
Excipient focus: BUTYL ALCOHOL
carbamazepine drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | carbamazepine | 16714-063 |
| Ajanta Pharma USA Inc | carbamazepine | 27241-231 |
| Zydus Pharmaceuticals (USA) Inc | carbamazepine | 68382-555 |
| REMEDYREPACK INC | carbamazepine | 70518-3929 |
| Zydus Lifesciences Limited | carbamazepine | 70771-1468 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing BUTYL ALCOHOL
Excipient focus: CELLULOSE ACETATE
carbamazepine drug variants containing CELLULOSE ACETATE
carbamazepine drug variants not containing CELLULOSE ACETATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
carbamazepine drug variants containing CELLULOSE, MICROCRYSTALLINE
carbamazepine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
carbamazepine drug variants containing CITRIC ACID MONOHYDRATE
carbamazepine drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: COLLOIDAL SILICON DIOXIDE
carbamazepine drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | carbamazepine | 16590-475 |
| State of Florida DOH Central Pharmacy | carbamazepine | 53808-0858 |
| Contract Pharmacy Services-PA | carbamazepine | 67046-086 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
carbamazepine drug variants containing CROSCARMELLOSE SODIUM
carbamazepine drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C YELLOW NO. 10
carbamazepine drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Nostrum Laboratories Inc | carbamazepine | 29033-019 |
| Amneal Pharmaceuticals NY LLC | carbamazepine | 69238-1213 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing D&C YELLOW NO. 10
Excipient focus: DEXTRATES
carbamazepine drug variants containing DEXTRATES
carbamazepine drug variants not containing DEXTRATES
Excipient focus: DIETHYL PHTHALATE
carbamazepine drug variants containing DIETHYL PHTHALATE
carbamazepine drug variants not containing DIETHYL PHTHALATE
Excipient focus: ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
carbamazepine drug variants containing ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | carbamazepine | 59746-789 |
| UMEDICA LABORATORIES PRIVATE LIMITED | carbamazepine | 60290-058 |
| REMEDYREPACK INC | carbamazepine | 70518-3699 |
| REMEDYREPACK INC | carbamazepine | 70518-3773 |
| REMEDYREPACK INC | carbamazepine | 70518-3911 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
Excipient focus: ETHYLCELLULOSE
carbamazepine drug variants containing ETHYLCELLULOSE
carbamazepine drug variants not containing ETHYLCELLULOSE
Excipient focus: ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A
carbamazepine drug variants containing ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | carbamazepine | 59746-789 |
| UMEDICA LABORATORIES PRIVATE LIMITED | carbamazepine | 60290-058 |
| REMEDYREPACK INC | carbamazepine | 70518-3699 |
| REMEDYREPACK INC | carbamazepine | 70518-3773 |
| REMEDYREPACK INC | carbamazepine | 70518-3911 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A
Excipient focus: ETHYLCELLULOSES
carbamazepine drug variants containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | carbamazepine | 54868-0147 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing ETHYLCELLULOSES
Excipient focus: FD&C BLUE NO. 1
carbamazepine drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Nostrum Laboratories Inc | carbamazepine | 29033-019 |
| Taro Pharmaceuticals USA Inc | carbamazepine | 51672-4151 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
carbamazepine drug variants containing FD&C BLUE NO. 2
carbamazepine drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 40
carbamazepine drug variants containing FD&C RED NO. 40
carbamazepine drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
carbamazepine drug variants containing FD&C YELLOW NO. 6
carbamazepine drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
carbamazepine drug variants containing FERRIC OXIDE RED
carbamazepine drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
carbamazepine drug variants containing FERRIC OXIDE YELLOW
carbamazepine drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
carbamazepine drug variants containing FERROSOFERRIC OXIDE
carbamazepine drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
carbamazepine drug variants containing GELATIN
carbamazepine drug variants not containing GELATIN
Excipient focus: GLYCERIN
carbamazepine drug variants containing GLYCERIN
carbamazepine drug variants not containing GLYCERIN
Excipient focus: HYDROCHLORIC ACID
carbamazepine drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Lundbeck Pharmaceuticals LLC | carbamazepine | 67386-621 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYDROXYETHYL CELLULOSE
carbamazepine drug variants containing HYDROXYETHYL CELLULOSE
carbamazepine drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: HYPROMELLOSE
carbamazepine drug variants containing HYPROMELLOSE
carbamazepine drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
carbamazepine drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | carbamazepine | 59746-789 |
| UMEDICA LABORATORIES PRIVATE LIMITED | carbamazepine | 60290-058 |
| REMEDYREPACK INC | carbamazepine | 70518-3699 |
| REMEDYREPACK INC | carbamazepine | 70518-3773 |
| REMEDYREPACK INC | carbamazepine | 70518-3911 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
carbamazepine drug variants containing HYPROMELLOSE 2910
carbamazepine drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
carbamazepine drug variants containing HYPROMELLOSES
carbamazepine drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
carbamazepine drug variants containing ISOPROPYL ALCOHOL
carbamazepine drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
carbamazepine drug variants containing LACTOSE MONOHYDRATE
carbamazepine drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
carbamazepine drug variants containing MAGNESIUM STEARATE
carbamazepine drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
carbamazepine drug variants containing MANNITOL
carbamazepine drug variants not containing MANNITOL
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
carbamazepine drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Nostrum Laboratories Inc | carbamazepine | 29033-019 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
carbamazepine drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0407 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
carbamazepine drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | carbamazepine | 54092-171 |
| Prasco Laboratories | carbamazepine | 66993-407 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
carbamazepine drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| VGYAAN Pharmaceuticals LLC | carbamazepine | 72664-218 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
carbamazepine drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Unichem Pharmaceuticals (USA) Inc | carbamazepine | 29300-382 |
| VGYAAN Pharmaceuticals LLC | carbamazepine | 72664-218 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: OLEIC ACID
carbamazepine drug variants containing OLEIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Nostrum Laboratories Inc | carbamazepine | 29033-019 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing OLEIC ACID
Excipient focus: POLOXAMER 188
carbamazepine drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | carbamazepine | 0904-7116 |
| Atlantic Biologicals Corps | carbamazepine | 17856-4047 |
| ANI Pharmaceuticals Inc | carbamazepine | 70954-240 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing POLOXAMER 188
Excipient focus: POLYETHYLENE GLYCOL
carbamazepine drug variants containing POLYETHYLENE GLYCOL
carbamazepine drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
carbamazepine drug variants containing POLYETHYLENE GLYCOL 400
carbamazepine drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 6000
carbamazepine drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | carbamazepine | 59746-789 |
| UMEDICA LABORATORIES PRIVATE LIMITED | carbamazepine | 60290-058 |
| REMEDYREPACK INC | carbamazepine | 70518-3699 |
| REMEDYREPACK INC | carbamazepine | 70518-3773 |
| REMEDYREPACK INC | carbamazepine | 70518-3911 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
carbamazepine drug variants containing POLYETHYLENE GLYCOL 8000
carbamazepine drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
carbamazepine drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Avera McKennan Hospital | carbamazepine | 69189-0410 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POTASSIUM SORBATE
carbamazepine drug variants containing POTASSIUM SORBATE
carbamazepine drug variants not containing POTASSIUM SORBATE
Excipient focus: POVIDONE
carbamazepine drug variants containing POVIDONE
carbamazepine drug variants not containing POVIDONE
Excipient focus: POWDERED CELLULOSE
carbamazepine drug variants containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| AustarPharma LLC | carbamazepine | 35561-355 |
| American Health Packaging | carbamazepine | 68084-561 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing POWDERED CELLULOSE
Excipient focus: PROPYLENE GLYCOL
carbamazepine drug variants containing PROPYLENE GLYCOL
carbamazepine drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
carbamazepine drug variants containing SHELLAC
carbamazepine drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
carbamazepine drug variants containing SILICON DIOXIDE
carbamazepine drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CITRATE
carbamazepine drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | carbamazepine | 62135-802 |
| Precision Dose Inc | carbamazepine | 68094-007 |
| Precision Dose Inc | carbamazepine | 68094-008 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
carbamazepine drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lundbeck Pharmaceuticals LLC | carbamazepine | 67386-621 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURETH SULFATE
carbamazepine drug variants containing SODIUM LAURETH SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| AustarPharma LLC | carbamazepine | 35561-355 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SODIUM LAURETH SULFATE
Excipient focus: SODIUM LAURYL SULFATE
carbamazepine drug variants containing SODIUM LAURYL SULFATE
carbamazepine drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
carbamazepine drug variants containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Lundbeck Pharmaceuticals LLC | carbamazepine | 67386-621 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
carbamazepine drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
carbamazepine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SORBITOL
carbamazepine drug variants containing SORBITOL
carbamazepine drug variants not containing SORBITOL
Excipient focus: SORBITOL SOLUTION
carbamazepine drug variants containing SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | carbamazepine | 62135-802 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SORBITOL SOLUTION
Excipient focus: STARCH, CORN
carbamazepine drug variants containing STARCH, CORN
carbamazepine drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
carbamazepine drug variants containing STARCH, PREGELATINIZED CORN
carbamazepine drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: SUCROSE
carbamazepine drug variants containing SUCROSE
carbamazepine drug variants not containing SUCROSE
Excipient focus: SULFOBUTYLETHER .BETA.-CYCLODEXTRIN
carbamazepine drug variants containing SULFOBUTYLETHER .BETA.-CYCLODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Lundbeck Pharmaceuticals LLC | carbamazepine | 67386-621 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SULFOBUTYLETHER .BETA.-CYCLODEXTRIN
Excipient focus: TALC
carbamazepine drug variants containing TALC
carbamazepine drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
carbamazepine drug variants containing TITANIUM DIOXIDE
carbamazepine drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIETHYL CITRATE
carbamazepine drug variants containing TRIETHYL CITRATE
carbamazepine drug variants not containing TRIETHYL CITRATE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
carbamazepine drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0029 |
| Morton Grove Pharmaceuticals Inc | carbamazepine | 60432-129 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: VANILLIN
carbamazepine drug variants containing VANILLIN
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0029 |
| Morton Grove Pharmaceuticals Inc | carbamazepine | 60432-129 |
| Chartwell RX LLC | carbamazepine | 62135-802 |
| Precision Dose Inc | carbamazepine | 68094-007 |
| Precision Dose Inc | carbamazepine | 68094-008 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing VANILLIN
Excipient focus: WATER
carbamazepine drug variants containing WATER
carbamazepine drug variants not containing WATER
Excipient focus: XANTHAN GUM
carbamazepine drug variants containing XANTHAN GUM
carbamazepine drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
